Search results for: 'due chapter sciences 2025'

Comprehensive Business Intelligence for Strategic Decision-Making

Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals

The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.

The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.

Essential Benchmark Data for Dealmakers  | Global coverage | Updated to 2025 | 15+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends

Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2025

Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025

Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025

Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025